Castle Creek Arbitrage’s Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 GLS.WS Stock Holding History

Castle Creek Arbitrage’s Portfolio GLS.WS Stock Details GLS.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-141,423	Closed	-$919	–	613
2022 Q4	$919	Hold	141,423	–	–	﹤0.01%	510
2022 Q3	$7K	Hold	141,423	–	–	﹤0.01%	576
2022 Q2	$17K	Hold	141,423	–	–	﹤0.01%	528
2022 Q1	$32K	Buy	+141,423	New	+$33.1K	﹤0.01%	555

Other funds holding GLS.WS

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

FIG

Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return

Castle Creek Arbitrage's GLS.WS Position: Q1 2023 in Review

Castle Creek Arbitrage sold out of Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 (GLS.WS) in Q1 2023, closing a stake of 141,423 shares — an estimated $919 sold.

Castle Creek Arbitrage first reported a position in GLS.WS in Q1 2022 and held it in 4 quarters. The position peaked at $32K in Q1 2022. 4 funds tracked by Wall St. Rank hold GLS.WS as of Q1 2023.

Castle Creek Arbitrage reported no remaining Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 position as of Q1 2023 after selling out during the quarter.
Castle Creek Arbitrage sold 141,423 Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 shares in Q1 2023, an estimated $919.
Castle Creek Arbitrage first reported a position in Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 in Q1 2022 and held it in 4 quarters.
Castle Creek Arbitrage's Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 position peaked at $32K in Q1 2022.
4 funds tracked by Wall St. Rank held Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 as of Q1 2023.

Based on Castle Creek Arbitrage's 13F filing for Q1 2023, filed 15 May 2023.